NEW YORK, NY (IANS) – Ritu Kalra, an investment banking and financial management expert, has been appointed as Harvard University’s vice president for finance and chief financial officer. Currently ...

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Membership (fee-based) Ritu Kapoor, CMO at Observe.AI, leading brand and GTM strategy ...

We now know what Bianca Censori’s BIO POP (THE ORIGIN) is, and furniture does play a key part after all. Thursday (Dec. 11), Censori launched the previously teased project in Seoul, revealing—as had ...

Pithy yet powerful, the Instagram bio can turn a casual scroller into an engaged follower—or send them straight to the back button. Let’s dive into the do’s and don’ts of crafting a bio that actually ...

In 1950, James Baldwin and his lover, the painter Lucien Happersberger, set out from Paris for the mountains of Switzerland, where Baldwin, then around 25, hoped to climb his way out of a creative ...

Ritu Raman on bio-robots merging living cells & tech to restore human mobility. Insoo Hyun talks with engineer Ritu Raman about bio-robots, machines powered by living muscle cells, to restore mobility ...

We run a highly concentrated portfolio of high-quality companies from around the world and some Bitcoin, which we share openly every quarter here on Seeking Alpha. We benchmark our performance against ...

Chatting recently about the new Bradley Collection feature exhibition at Milwaukee Art Museum, it struck me that some of the nearly 400 works that the late Peg Bradley donated to the museum are what ...

Borderlands 4’s Bio-Bulkhead is one of the first bosses you fight in the game and the grappling hook is fundamental to get to the boss. Unlike anything you have faced so far in the game, Bio-Bulkhead ...

Generation Bio is shedding 90% of its workforce after the biotech acknowledged it’s unlikely to find the cash to take its lipid nanoparticle tech into the clinic. The Massachusetts-based company has ...